Monday, September 14, 2026

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

BLACKPINK’s Lisa Apologizes: What Went Wrong at the 10th Anniversary Event?

BLACKPINK member Lisa apologized for the controversy surrounding the 10th-anniversary fan event, expressing her sincere regret.

Tag: easing tensions

No posts to display

Top News

- Our Sponsors Ad -

Follow us